Your browser doesn't support javascript.
Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations.
Botton, Jérémie; Semenzato, Laura; Jabagi, Marie-Joëlle; Baricault, Bérangère; Weill, Alain; Dray-Spira, Rosemary; Zureik, Mahmoud.
  • Botton J; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, Saint-Denis, France.
  • Semenzato L; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, Saint-Denis, France.
  • Jabagi MJ; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, Saint-Denis, France.
  • Baricault B; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, Saint-Denis, France.
  • Weill A; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, Saint-Denis, France.
  • Dray-Spira R; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, Saint-Denis, France.
  • Zureik M; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, Saint-Denis, France.
JAMA Netw Open ; 5(3): e220868, 2022 03 01.
Article in English | MEDLINE | ID: covidwho-1718201
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Vaccine Efficacy / BNT162 Vaccine / Ad26COVS1 / Hospitalization Type of study: Experimental Studies / Observational study Topics: Vaccines Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: JAMA Netw Open Year: 2022 Document Type: Article Affiliation country: JAMANETWORKOPEN.2022.0868

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Vaccine Efficacy / BNT162 Vaccine / Ad26COVS1 / Hospitalization Type of study: Experimental Studies / Observational study Topics: Vaccines Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: JAMA Netw Open Year: 2022 Document Type: Article Affiliation country: JAMANETWORKOPEN.2022.0868